首页 | 本学科首页   官方微博 | 高级检索  
     

肝硬化合并肝源性糖尿病患者C肽释放试验临床研究
引用本文:李平. 肝硬化合并肝源性糖尿病患者C肽释放试验临床研究[J]. 中国现代医药杂志, 2011, 13(5): 73-74
作者姓名:李平
作者单位:贵州省安顺市人民医院消化内科,561000
摘    要:目的探讨C肽(C-Peptide)释放试验在不同程度肝硬化合并肝源性糖尿病患者中的应用价值。方法应用化学发光检测方法对45例肝硬化合并肝源性糖尿病和23例初诊2型糖尿病进行了C肽释放试验的检测对照。结果各级肝硬化合并肝源性糖尿病患者C肽释放试验均较对照组明显增加,两者间差异有显著性(P<0.01)。结论 C肽释放试验在鉴别肝源性糖尿病中有一定的应用价值,对肝硬化程度的判定有重要意义。

关 键 词:肝硬化合并肝源性糖尿病  C肽释放试验

The study C-Peptide release test on the patients with the various degree liver cirrhosis combined hepatic diabetes
Li Ping. The study C-Peptide release test on the patients with the various degree liver cirrhosis combined hepatic diabetes[J]. Modern Medicine Journal of China, 2011, 13(5): 73-74
Authors:Li Ping
Affiliation:Li Ping.The People's Hospital of Anshun,Anshun 561000
Abstract:Objective To explore the function of C-Peptide release test on the patients with the various degree liver cirrhosis combined hepatic diabetes.Methods 45 cases with liver cirrhosis combined hepatic diabetes and 23 patients newly diagnosed type 2 diabetes were detected by C-Peptide release test,respectively.Results The results of C-Peptide release test of the patients with the various degree liver cirrhosis combined hepatic diabetes were significantly increased than that of the control group,and the differenc...
Keywords:Hepatic diabetes C-Peptide release test  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号